Valent BioSciences LLC is now selling biostimulant products directly to its U.S. customer base, via its new biostimulant operating unit that was established in February 2022.
Valent said the new biostimulant business team and salesforce are focused on discovering, developing and commercializing arbuscular mycorrhizal fungi (AMF) products, among other biostimulants, to sustainably maximize retailer and grower profitability. The company states this transition marks a major change in the go-to-market strategy for Valent BioSciences.
“As both market volatility and the global population increase, biostimulants can be used to sustainably improve crop performance and ROI,” said Salman Mir, executive vice president and chief operating officer at Valent BioSciences. “Biostimulant products, including our AMF technologies, also support the mission of our parent company, Sumitomo Chemical Co., Ltd., for achieving carbon neutrality by 2050, as well as its global goal of attaining carbon neutrality for society as a whole.”
The core Valent BioSciences biostimulant products are being marketed under the Symvado and Proliant brand names. The new biostimulants business team is focused on achieving customer success with biostimulants and will be employing a variety of newly created tools and digital assets to support commercialization of these brands in the U.S. market.
“We recognize that biostimulants can be challenging products for customers to successfully utilize, so we are adapting our strategy to best address customer needs and drive value for all parties,” said Dave Schumacher, vice president of commercial operations for Valent BioSciences.